Congratulations on the official launch and operation of our company’s website!
Release time:
2023-09-21 09:55
Congratulations on the official launch and operation of our company’s website!
Tianjin Olive Biotechnology Co., Ltd., located in the TEDA Modern Industrial Zone, Binhai New Area, Tianjin, is a company integrating the research and development, production, and sales of nucleosides, nucleotides and their derivatives, fluorescent probes, and core raw materials for gene sequencing. Olive has now established a fully DCS-controlled automated production facility and strictly adheres to ISO9001, ISO14001, and ISO45001 management standards. The company meticulously controls every stage—from raw material procurement and process monitoring to finished-product testing, environmental protection, and production safety—ensuring high-quality and stable supply to meet customer needs and offering customized supply services tailored to specific requirements. The company’s testing center is CNAS-accredited and boasts a domestically leading platform for nucleoside chemical modification and purification technologies. Our products find applications in areas such as molecular diagnostics, gene sequencing, small nucleic acid therapeutics, and mRNA vaccines/drugs.
Dr. Ma Long, founder of Olive, graduated from the School of Medicine at Peking University and earned a PhD in the UK. He has extensive R&D experience in the development of small-molecule innovative drugs and nucleoside chemistry. The R&D team led by Dr. Ma Long has successfully developed several nucleoside and nucleotide products and has achieved their industrial-scale production.
Tianjin Lianlong New Materials Co., Ltd. (stock code: 300596) is the controlling shareholder of Olive. Leveraging Lianlong’s strengths in engineering design, large-scale plant construction, production management, and quality control within the fine chemical industry, Olive aims to use its portfolio of nucleic acid drug raw materials and biofluorescent probe-based detection products as a starting point for development, gradually evolving into a world-class, high-tech biopharmaceutical testing reagent platform.
Relevant Information
Service hotline:
Company email:
Share
